Life Technologies to acquire BioTrove Inc
LIFE | Quote | Chart | News | PowerRating -- Biotechnology tools company Life Technologies Corporation (NASDAQ:LIFE)
said on Tuesday that it has entered into a definitive agreement to
acquire BioTrove Inc.
Financial terms of the deal were not disclosed.
BioTrove's technology is expected to complement Life Technologies'
polymerase chain reaction (PCR) portfolio.
The primary technology of BioTrove is the OpenArray platform, a high
throughput gene expression and genotyping analysis system based on a
flexible array format that enables researchers to perform more than
3,000 PCR genotyping or qPCR gene expression assays at a time.
This acquisition builds on a collaboration formed in 2007 between
BioTrove and Life Technologies' subsidiary Applied Biosystems, in which
Applied Biosystems assumed responsibility for commercialisation of the
OpenArray business for genotyping applications.
Comments on this story may be sent to admin@m2.com
For full details on Life Technologies Corporation (LIFE) LIFE. Life Technologies Corporation (LIFE) has Short Term PowerRatings at TradingMarkets. Details on Life Technologies Corporation (LIFE) Short Term PowerRatings is available at This Link.
- Telegraph Hill Partners sells AcroMetrix to Life Technologies - 02/02/10
- Life Technologies acquires AcroMetrix - 02/02/10
- Danaher acquires remaining 50% stake in AB SCIEX from Life Technologies - 02/02/10
- Life Technologies Responds to Challenge of Detecting Vesivirus 2117 Contamination in Mammalian Cell Culture Manufacturing - 02/02/10
- Life Technologies Posts 4Q and Fiscal Year 2009 Results - 02/02/10
- More News >>


